Fetal Intraperitoneal Immunoglobulin for Autoimmune Myocarditis and AV Block

This case series demonstrates the feasibility and potential safety of IPIG as a novel fetal immunomodulatory therapy. Although outcomes were encouraging, efficacy cannot be established without larger comparative studies.

Authors

Institutions

Publication Details

Journal
JACC Case Reports
Published
2025-12-12
DOI
https://doi.org/10.1016/j.jaccas.2025.106489
Primary Topic
Parvovirus B19 Infection Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fetal Intraperitoneal Immunoglobulin for Autoimmune Myocarditis and AV Block

Shweta Bakhru, Nageswara Rao Koneti, Bhargavi Dhulipudi
JACC Case Reports
Parvovirus B19 Infection Studies
article

Fetal Intraperitoneal Immunoglobulin for Autoimmune Myocarditis and AV Block

Shweta Bakhru, Nageswara Rao Koneti, Bhargavi Dhulipudi
article en

Abstract

This case series demonstrates the feasibility and potential safety of IPIG as a novel fetal immunomodulatory therapy. Although outcomes were encouraging, efficacy cannot be established without larger comparative studies.

JACC Case ReportsVol. 31(6)
Rainbow Children's Hospital (IN)
Openalex Percentile: Top 54%
Parvovirus B19 Infection Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fetal Intraperitoneal Immunoglobulin for Autoimmune Myocarditis and AV Block — Shweta Bakhru, Nageswara Rao Koneti, et al. · JACC Case Reports (2025) | TGRS Research Map | TGRS